New generic paclitaxel put to the test in breast cancer patients
NCT ID NCT06765590
First seen Apr 10, 2026 · Last updated May 13, 2026 · Updated 4 times
Summary
This study compares a generic version of the chemotherapy drug paclitaxel to the standard brand in 24 people with breast cancer. Participants receive one dose of each drug in random order to see if the generic works the same way in the body. The goal is to confirm the generic is a safe and effective alternative.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated hospital of Hennan University of Science & Technology
RECRUITINGLuoyang, Henan, 471003, China
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.